NASDAQ:ARCT - Arcturus Therapeutics Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $4.97 +0.13 (+2.69 %) (As of 02/20/2019 04:00 PM ET)Previous Close$4.84Today's Range$4.71 - $4.9752-Week Range$4.11 - $10.00Volume25,400 shsAverage Volume28,553 shsMarket Capitalization$53.40 millionP/E Ratio-1.41Dividend YieldN/ABeta2.14 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Arcturus Therapeutics (NASDAQ:ARCT) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.4 Wall Street analysts have issued ratings and price targets for Arcturus Therapeutics in the last 12 months. There are currently 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 22.214.171.124.75Ratings Breakdown: 0 Sell Rating(s)0 Hold Rating(s)3 Buy Rating(s)1 Strong Buy Rating(s)0 Sell Rating(s)0 Hold Rating(s)3 Buy Rating(s)1 Strong Buy Rating(s)0 Sell Rating(s)0 Hold Rating(s)3 Buy Rating(s)1 Strong Buy Rating(s)0 Sell Rating(s)1 Hold Rating(s)3 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: N/A$12.00$12.00$5.00Price Target Upside: N/A35.75% upside35.75% upside37.58% downsideArcturus Therapeutics (NASDAQ:ARCT) Consensus Price Target History Arcturus Therapeutics (NASDAQ:ARCT) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails2/19/2019LaidlawInitiated CoverageBuyLow9/27/2018Brookline Capital ManagementReiterated RatingBuyLow9/20/2018WBB SecuritiesUpgradeBuy ➝ Strong-BuyLow5/31/2018LADENBURG THALM/SH SHUpgradeNeutral ➝ BuyHigh1/22/2018Chardan CapitalInitiated CoverageBuy ➝ Buy$12.00High9/29/2017Roth CapitalDowngradeBuy ➝ Neutral$4.00 ➝ $1.00Low6/12/2017Jefferies Financial GroupReiterated RatingHold$1.25Low4/13/2017Cantor FitzgeraldReiterated RatingHold$1.00Low(Data available from 2/20/2017 forward) This page was last updated on 2/20/2019 by MarketBeat.com StaffFeatured Article: What is a balanced fund?